Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.110
-0.090 (-4.09%)
Nov 21, 2024, 3:46 PM EST - Market closed
Edesa Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
Net Income | -6.93 | -8.37 | -17.55 | -13.34 | -6.36 | -3.14 | |
Depreciation & Amortization | 0.19 | 0.18 | 0.12 | 0.12 | 0.06 | 0.01 | |
Stock-Based Compensation | 0.96 | 1.25 | 2.26 | 3.2 | 0.6 | 0.05 | |
Change in Accounts Receivable | -0.51 | 0.56 | 2.03 | -3.23 | 0.13 | 0.01 | |
Change in Inventory | - | - | - | - | - | 0.08 | |
Change in Accounts Payable | 0.85 | -0.56 | 0.88 | -0.12 | 1 | -1.92 | |
Change in Other Net Operating Assets | 0.07 | 0.3 | -0.02 | -0.28 | -0.4 | -0.31 | |
Operating Cash Flow | -5.39 | -6.64 | -12.28 | -13.66 | -4.99 | -5.23 | |
Capital Expenditures | - | - | -0.01 | -0.01 | -0 | -0.01 | |
Sale of Property, Plant & Equipment | - | - | - | - | 0.05 | 0.04 | |
Cash Acquisitions | - | - | - | - | - | 6.39 | |
Sale (Purchase) of Intangibles | - | - | - | - | -0.03 | - | |
Investing Cash Flow | - | - | -0.01 | -0.01 | 0.02 | 6.42 | |
Long-Term Debt Issued | - | - | - | - | 0.03 | - | |
Total Debt Issued | - | - | - | - | 0.03 | - | |
Net Debt Issued (Repaid) | -0.03 | - | - | - | 0.03 | - | |
Issuance of Common Stock | 1.21 | 5.12 | 11.96 | 14.36 | 7.6 | - | |
Other Financing Activities | -0.15 | -0.29 | -0.33 | -0.19 | -0.53 | - | |
Financing Cash Flow | 1.04 | 4.83 | 11.63 | 14.17 | 7.09 | - | |
Foreign Exchange Rate Adjustments | -0.06 | 0.08 | -0.09 | 0.12 | 0.06 | 0.11 | |
Net Cash Flow | -4.42 | -1.73 | -0.75 | 0.63 | 2.18 | 1.3 | |
Free Cash Flow | -5.39 | -6.64 | -12.28 | -13.67 | -4.99 | -5.24 | |
Free Cash Flow Margin | - | - | - | - | -1518.00% | -1274.42% | |
Free Cash Flow Per Share | -1.72 | -2.32 | -5.86 | -7.92 | -4.06 | -7.99 | |
Levered Free Cash Flow | -3.77 | -3.78 | -6.12 | -14.93 | -2.66 | - | |
Unlevered Free Cash Flow | -3.77 | -3.78 | -6.12 | -14.93 | -2.66 | - | |
Change in Net Working Capital | -0.32 | -0.55 | -2.99 | 3.44 | -0.72 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.